Consistent with the assumption that the hypoxic state increases the resistance of breast cancer cells to DOX and the hypoxic state itself induces HIF-1α overexpression, targeting HIF-1α may overcome therapeutic resistance. This evidence concerns the gene HIF1A and breast carcinoma.